Recent QNRX News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 10:07:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2024 08:30:08 PM
- Quoin Pharmaceuticals Announces Insider Share Purchases by Co-Founders CEO and COO • GlobeNewswire Inc. • 09/09/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 04:06:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 04:03:37 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/12/2024 08:32:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:01:28 PM
- Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/08/2024 12:30:00 PM
- Quoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin Syndrome • GlobeNewswire Inc. • 08/06/2024 09:00:00 AM
- Quoin Pharmaceuticals to Announce Second Quarter 2024 Financial Results on Thursday, August 8, 2024 • GlobeNewswire Inc. • 08/01/2024 08:10:00 PM
- Quoin Pharmaceuticals Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome • GlobeNewswire Inc. • 06/27/2024 12:00:00 PM
- Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference • GlobeNewswire Inc. • 06/25/2024 08:05:00 PM
- Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland • GlobeNewswire Inc. • 06/12/2024 12:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/10/2024 08:10:54 PM
- Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/09/2024 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/08/2024 08:00:53 PM
- Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024 • GlobeNewswire Inc. • 05/02/2024 08:10:00 PM
- Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results • GlobeNewswire Inc. • 03/13/2024 08:05:00 PM
- Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb • IH Market News • 03/13/2024 11:03:39 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/08/2024 09:06:10 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/08/2024 09:04:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:01:51 PM
- Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET • GlobeNewswire Inc. • 03/07/2024 09:05:00 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 03/06/2024 10:07:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:01:40 PM
FEATURED CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • Oct 8, 2024 8:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM